CN110101905A - A kind of iron content polyacrylate bone cement and preparation method - Google Patents
A kind of iron content polyacrylate bone cement and preparation method Download PDFInfo
- Publication number
- CN110101905A CN110101905A CN201910454290.XA CN201910454290A CN110101905A CN 110101905 A CN110101905 A CN 110101905A CN 201910454290 A CN201910454290 A CN 201910454290A CN 110101905 A CN110101905 A CN 110101905A
- Authority
- CN
- China
- Prior art keywords
- bone cement
- powder
- iron
- liquid
- polyacrylate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/02—Inorganic materials
- A61L27/025—Other specific inorganic materials not covered by A61L27/04 - A61L27/12
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/16—Macromolecular materials obtained by reactions only involving carbon-to-carbon unsaturated bonds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/54—Biologically active materials, e.g. therapeutic substances
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/10—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing inorganic materials
- A61L2300/102—Metals or metal compounds, e.g. salts such as bicarbonates, carbonates, oxides, zeolites, silicates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/404—Biocides, antimicrobial agents, antiseptic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2400/00—Materials characterised by their function or physical properties
- A61L2400/06—Flowable or injectable implant compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2430/00—Materials or treatment for tissue regeneration
- A61L2430/02—Materials or treatment for tissue regeneration for reconstruction of bones; weight-bearing implants
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Transplantation (AREA)
- Epidemiology (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Dermatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Inorganic Chemistry (AREA)
- Materials For Medical Uses (AREA)
- Curing Cements, Concrete, And Artificial Stone (AREA)
Abstract
Description
技术领域technical field
本发明涉及一种含铁聚丙烯酸酯骨水泥及制备方法,属于骨科材料领域。The invention relates to an iron-containing polyacrylate bone cement and a preparation method, and belongs to the field of orthopedic materials.
背景技术Background technique
聚丙烯酸酯(PMMA)骨水泥是目前临床上应用最多的一种骨水泥,它由粉体和液体两部分组成。粉体主要成分为聚甲基丙烯酸甲酯,液体主要成分是甲基丙烯酸甲酯单体。骨水泥可注射成型和制成任意形状,具有力学强度良好,性能稳定等优点,是目前应用广泛的椎体成形术材料。目前国内市场上PMMA骨水泥至少有40多种,被广泛应用于骨科填充材料和固定材料,尤其应用于椎体成形术治疗椎体压缩性骨折,能迅速稳定损伤的椎体,缓解患者的症状。但同时骨水泥还存在一些局限性,如力学性能稍差,与周围组织融合差。因此改性PMMA骨水泥的研究尤为重要,通过性能的改良,提高其理化性质和生物学性能。Polyacrylate (PMMA) bone cement is currently the most widely used bone cement in clinical practice. It consists of powder and liquid. The main component of powder is polymethyl methacrylate, and the main component of liquid is methyl methacrylate monomer. Bone cement can be injection molded and made into any shape. It has the advantages of good mechanical strength and stable performance. It is currently a widely used vertebroplasty material. At present, there are at least 40 kinds of PMMA bone cement on the domestic market, which are widely used in orthopedic filling materials and fixation materials, especially in the treatment of vertebral compression fractures by vertebroplasty, which can quickly stabilize the injured vertebral body and relieve the symptoms of patients. . However, there are still some limitations of bone cement, such as slightly poor mechanical properties and poor fusion with surrounding tissues. Therefore, the research on modified PMMA bone cement is particularly important. Through the improvement of performance, its physical and chemical properties and biological properties can be improved.
磁物质中研究比较多的是四氧化三铁,俗称氧化铁黑、磁铁等,为具有磁性的黑色晶体,故又称为磁性氧化铁。作为一种多功能磁性材料,在肿瘤的治疗、微波吸收材料、催化剂载体、细胞分离、磁记录材料、磁流体、医药等领域均已有广泛的应用。磁性骨水泥即将具有磁性的物质引入到骨水泥中,赋予骨水泥良好的磁性,同时改善骨水泥的力学性能,而目前含磁性氧化铁的骨水泥却鲜有报道。Among the magnetic substances, the most studied is iron tetroxide, commonly known as iron oxide black, magnets, etc. It is a black crystal with magnetic properties, so it is also called magnetic iron oxide. As a multifunctional magnetic material, it has been widely used in tumor treatment, microwave absorption material, catalyst carrier, cell separation, magnetic recording material, magnetic fluid, medicine and other fields. Magnetic bone cement is about introducing a magnetic substance into the bone cement, giving the bone cement good magnetic properties and improving the mechanical properties of the bone cement. However, there are few reports on the bone cement containing magnetic iron oxide.
因此本发明中设计一种含铁聚丙烯酸酯骨水泥,在制备PMMA粉体的过程中引入四氧化三铁,赋予PMMA一定的磁性,并控制反应的配比制备含铁PMMA,并将其与聚丙烯酸酯、硫酸钡等复合制备骨水泥,通过磁性四氧化三铁的引入,在骨水泥中可通过磁滞现象加热,达到磁疗杀菌的作用,同时改善骨水泥的可注射性和力学强度,提高骨水泥的生物相容性和骨诱导性。对本发明相关内容的研究未见报道。Therefore, a kind of iron-containing polyacrylate bone cement is designed in the present invention. In the process of preparing PMMA powder, ferric tetroxide is introduced to give PMMA certain magnetic properties, and the ratio of the reaction is controlled to prepare iron-containing PMMA, and it is mixed with Bone cement is prepared by compounding polyacrylate, barium sulfate, etc. Through the introduction of magnetic ferric oxide, the bone cement can be heated by magnetic hysteresis to achieve the effect of magnetic therapy and sterilization, and at the same time improve the injectability and mechanical strength of bone cement , to improve the biocompatibility and osteoinductivity of bone cement. There is no report on the research on the relevant content of the present invention.
发明内容SUMMARY OF THE INVENTION
本发明的目的在于提供一种含铁聚丙烯酸酯骨水泥及制备方法,在制备聚丙烯酸酯粉末过程中掺入四氧化三铁可改善聚丙烯酸酯粉末的粒径分布范围,提高骨水泥的可注射性,并且提高骨水泥的力学性能,其抗压强度高达80.82MPa。其次四氧化三铁的引入赋予骨水泥磁性,在骨水泥中可通过磁滞损失现象加热,达到磁疗杀菌的作用,同时赋予骨水泥良好的生物相容性和骨诱导性。The purpose of the present invention is to provide an iron-containing polyacrylate bone cement and a preparation method. In the process of preparing the polyacrylate powder, adding ferric tetroxide can improve the particle size distribution range of the polyacrylate powder and improve the availability of the bone cement. Injectable, and improve the mechanical properties of bone cement, its compressive strength is as high as 80.82MPa. Secondly, the introduction of ferric tetroxide imparts magnetic properties to the bone cement, which can be heated by the hysteresis loss phenomenon in the bone cement to achieve the effect of magnetic therapy sterilization, and at the same time endow the bone cement with good biocompatibility and osteoinductivity.
本发明的技术方案如下:The technical scheme of the present invention is as follows:
一种含铁聚丙烯酸酯骨水泥,其骨水泥组成及质量百分含量为:An iron-containing polyacrylate bone cement, the bone cement composition and mass percentage are:
粉体:Powder:
含铁聚丙烯酸酯 65%~89%;Iron-containing polyacrylate 65% to 89%;
硫酸钡 10%~30%;Barium sulfate 10% to 30%;
过氧化苯甲酰 1%~5%;Benzoyl peroxide 1% to 5%;
液体:liquid:
N,N二甲基对甲苯胺 0.5%~5%;N,N-dimethyl-p-toluidine 0.5%~5%;
对苯二酚 0.05%~2%;Hydroquinone 0.05%~2%;
甲基丙烯酸甲酯 93~99.45%;Methyl methacrylate 93-99.45%;
粉体和液体质量比 1~3:1。The mass ratio of powder to liquid is 1 to 3:1.
本发明的含铁聚丙烯酸酯骨水泥的制备方法,包括如下步骤:The preparation method of the iron-containing polyacrylate bone cement of the present invention comprises the following steps:
1)按照粉体的质量百分含量称取含铁聚丙烯酸酯、硫酸钡及过氧化苯甲酰,均匀混合得到骨水泥粉体;1) Weigh iron-containing polyacrylate, barium sulfate and benzoyl peroxide according to the mass percentage of the powder, and uniformly mix to obtain the bone cement powder;
2)按照粉液质量比1~3:1,将粉体加入液体中混合均匀,固化得到含铁聚丙烯酸酯骨水泥,骨水泥注射时间为5~12min;2) According to the mass ratio of powder to liquid of 1~3:1, add the powder into the liquid and mix evenly, solidify to obtain iron-containing polyacrylate bone cement, and the injection time of the bone cement is 5~12min;
其中:含铁聚丙烯酸酯粉末的制备方法如下:Wherein: the preparation method of iron-containing polyacrylate powder is as follows:
(1)按照四氧化三铁:十六烷基三甲基溴化铵:甲基丙烯酸甲脂摩尔比为0.1~0.5:0.2:1将四氧化三铁、十六烷基三甲基溴化铵加入到甲基丙烯酸甲酯中,超声分散,再机械搅拌得到四氧化三铁的悬浊液体;(1) According to the ferric oxide: cetyl trimethyl ammonium bromide: methyl methacrylate molar ratio of 0.1 ~ 0.5: 0.2: 1, ferric tetroxide, cetyl trimethyl bromide Ammonium is added to methyl methacrylate, ultrasonically dispersed, and then mechanically stirred to obtain a suspension liquid of ferric oxide;
(2)配置含有0.2~3%的过氧化二苯甲酰(BPO)悬浊液,溶液温度为90~135℃,随后加入0.001%~0.002%十二烷基硫醇到BPO悬浊液中并持续搅拌,得到含有十二烷基硫醇的BPO悬浊液;(2) Prepare a suspension containing 0.2-3% dibenzoyl peroxide (BPO), the solution temperature is 90-135°C, and then add 0.001%-0.002% dodecyl mercaptan to the BPO suspension And continue to stir to obtain the BPO suspension containing dodecyl mercaptan;
(3)将步骤(1)制备的四氧化三铁的悬浊液体在搅拌过程中升温到60~80℃后加入到BPO悬浊液中,混合均匀持续搅拌反应,水洗干燥过滤,得到含铁聚丙烯酸酯粉末。(3) the suspension liquid of ferric tetroxide prepared in step (1) is heated to 60~80 ℃ and then added to the BPO suspension liquid in the stirring process, uniformly mixed and continuously stirred for reaction, washed with water, dried and filtered to obtain iron-containing liquid Polyacrylate powder.
所述步骤(1)中超声分散条件是5KHz超声分散10~30min。The ultrasonic dispersion condition in the step (1) is 5KHz ultrasonic dispersion for 10-30 minutes.
所述步骤(1)中机械搅拌10~30min,搅拌速率为600~1200rpm。In the step (1), mechanical stirring is performed for 10-30 min, and the stirring rate is 600-1200 rpm.
所述步骤(2)中搅拌时间为4-8h,搅拌速率为600~1200rpm。In the step (2), the stirring time is 4-8 h, and the stirring speed is 600-1200 rpm.
所述步骤(3)中四氧化三铁的悬浊液与BPO悬浊液的质量比为1:1,搅拌反应12~36h,搅拌速率为600~1200rpm。In the step (3), the mass ratio of the ferric oxide suspension to the BPO suspension is 1:1, the stirring reaction is performed for 12-36 hours, and the stirring rate is 600-1200 rpm.
所述含铁聚丙烯酸酯粒度分布范围为0.2~100μm。The particle size distribution range of the iron-containing polyacrylate is 0.2-100 μm.
本发明的优点在于:在聚丙烯酸酯粉体的制备过程中引入了四氧化三铁,制备的含铁聚丙烯酸酯粉末的粒度分布范围为0.2~100μm,提高了骨水泥的可注射性。其次骨水泥的力学性能得到改善,其抗压强度高达80.82MPa。此外含铁聚丙烯酸酯的引入赋予聚丙烯酸酯粉体一定的磁性,骨水泥植入到缺损处时,可通过磁场强度的改变,利用磁滞加热骨水泥,起到杀菌抑菌的功能。另一方面由于四氧化三铁的加入,减少了骨水泥聚合过程中能量的急剧释放,降低了骨水泥聚合对组织的热损伤,转而为可控温度,起到在不损伤组织的前提下,达到杀菌抑菌的功效,具有良好的生物相容性和骨诱导性,可用于多种骨折的固定、骨缺损的填充。The advantages of the present invention lie in that ferric tetroxide is introduced in the preparation process of the polyacrylate powder, the particle size distribution range of the prepared iron-containing polyacrylate powder is 0.2-100 μm, and the injectability of the bone cement is improved. Secondly, the mechanical properties of bone cement were improved, and its compressive strength was as high as 80.82MPa. In addition, the introduction of iron-containing polyacrylate imparts certain magnetic properties to the polyacrylate powder. When the bone cement is implanted in the defect, the bone cement can be heated by magnetic hysteresis through the change of the magnetic field strength, which has the function of bactericidal and bacteriostatic. On the other hand, due to the addition of ferric oxide, the rapid release of energy in the process of bone cement polymerization is reduced, and the thermal damage to the tissue caused by bone cement polymerization is reduced. , to achieve the effect of bactericidal and bacteriostatic, with good biocompatibility and osteoinductivity, and can be used for the fixation of various fractures and the filling of bone defects.
附图说明Description of drawings
图1:含铁骨水泥的抗压强度图。Figure 1: Compressive strength graph of iron-containing bone cement.
具体实施方式Detailed ways
下面结合实施例对本发明的内容作进一步的详细说明,但本发明的实施方式不限于此。The content of the present invention will be further described in detail below with reference to the examples, but the embodiments of the present invention are not limited thereto.
含铁聚丙烯酸酯骨水泥的制备方法如下:The preparation method of iron-containing polyacrylate bone cement is as follows:
(1)按照四氧化三铁:十六烷基三甲基溴化铵:甲基丙烯酸甲脂摩尔比为0.1~0.5:0.2:1将四氧化三铁、十六烷基三甲基溴化铵加入到甲基丙烯酸甲酯中,5KHz超声分散10~30min,再机械搅拌10~30min得到四氧化三铁的悬浊液体,搅拌速率为600~1200rpm。(1) According to the ferric oxide: cetyl trimethyl ammonium bromide: methyl methacrylate molar ratio of 0.1 ~ 0.5: 0.2: 1, ferric tetroxide, cetyl trimethyl bromide Ammonium is added to methyl methacrylate, 5KHz ultrasonic dispersion is performed for 10-30 minutes, and mechanical stirring is performed for 10-30 minutes to obtain a suspension liquid of ferric oxide, and the stirring speed is 600-1200 rpm.
(2)配置含有0.2~3%的BPO悬浊液,溶液温度为90~135℃,随后加入0.001%~0.002%十二烷基硫醇到BPO悬浊液中并持续搅拌4~8h,搅拌速率为600~1200rpm;(2) Prepare a BPO suspension containing 0.2-3%, the solution temperature is 90-135°C, then add 0.001%-0.002% dodecyl mercaptan to the BPO suspension and continue stirring for 4-8h, stirring The speed is 600~1200rpm;
(3)将步骤(1)制备的四氧化三铁的悬浊液体在搅拌过程中升温到60~80℃,加入到步骤(2)的BPO悬浊液中,四氧化三铁的悬浊液与BPO悬浊液的质量比为1:1,持续搅拌反应12~36h,搅拌速率为600~1200rpm,水洗干燥过滤,即可得到含铁聚丙烯酸酯粉末;(3) the suspension liquid of ferric tetroxide prepared in step (1) is heated to 60~80° C. in the stirring process, and added to the BPO suspension liquid of step (2), the suspension liquid of ferric oxide The mass ratio to the BPO suspension is 1:1, the reaction is continuously stirred for 12 to 36 hours, the stirring speed is 600 to 1200 rpm, and the iron-containing polyacrylate powder can be obtained by washing with water, drying and filtering;
(4)按照粉体的质量百分含量称取含铁聚丙烯酸酯、硫酸钡及过氧化苯甲酰,均匀混合得到骨水泥粉体;(4) weighing iron-containing polyacrylate, barium sulfate and benzoyl peroxide according to the mass percentage of the powder, and uniformly mixing to obtain bone cement powder;
(5)按照粉液质量比1~3:1,将粉体加入液体中混合均匀,固化得到含铁聚丙烯酸酯骨水泥,骨水泥注射时间为5~12min。(5) According to the mass ratio of powder to liquid of 1 to 3:1, the powder is added to the liquid and mixed evenly, and solidified to obtain iron-containing polyacrylate bone cement, and the injection time of the bone cement is 5 to 12 minutes.
含铁聚丙烯酸酯粒度分布范围为0.2~100μm。The particle size distribution range of the iron-containing polyacrylate is 0.2-100 μm.
实施例1Example 1
骨水泥为粉体含有89g的含铁聚丙烯酸酯,10g硫酸钡,1g的过氧化苯甲酰;液体含有5g的N,N二甲基对甲苯胺,2g的对苯二酚,93g的甲基丙烯酸甲酯。Bone cement is powder containing 89g iron-containing polyacrylate, 10g barium sulfate, 1g benzoyl peroxide; liquid contains 5g N,N dimethyl-p-toluidine, 2g hydroquinone, 93g methyl alcohol Methyl acrylate.
含铁聚丙烯酸酯骨水泥及制备方法如下:The iron-containing polyacrylate bone cement and its preparation method are as follows:
(1)按照四氧化三铁:十六烷基三甲基溴化铵:甲基丙烯酸甲脂摩尔比为0.1:0.2:1将四氧化三铁23.154g、十六烷基三甲基溴化铵72.89g加入到甲基丙烯酸甲酯100.1g中,5KHz超声分散30min,再机械搅拌10min得到四氧化三铁的悬浊液体,搅拌速率600rpm;(1) 23.154 g of ferric oxide, hexadecyl trimethyl bromide, 23.154 g of ferric tetroxide, hexadecyl trimethyl bromide were 0.1:0.2:1 according to the molar ratio of ferric oxide: cetyl trimethyl ammonium bromide: methyl methacrylate 72.89g of ammonium was added to 100.1g of methyl methacrylate, 5KHz ultrasonic dispersion was carried out for 30min, and then mechanical stirring was performed for 10min to obtain a suspension liquid of ferric oxide, and the stirring speed was 600rpm;
(2)将3g BPO加入97g去离子水中,得到含有3%的BPO悬浊液,溶液温度为135℃,并加入0.002g十二烷基硫醇,持续搅拌4h,搅拌速率为600rpm;(2) 3g of BPO was added to 97g of deionized water to obtain a BPO suspension containing 3%, the solution temperature was 135°C, and 0.002g of dodecyl mercaptan was added, and the stirring was continued for 4h at a stirring speed of 600rpm;
(3)将四氧化三铁的悬浊液体100g在搅拌过程中升温到80℃,加入到100g BPO悬浊液中,持续搅拌反应12h,搅拌速率为600rpm,水洗干燥过滤,即可得到含铁聚丙烯酸酯粉末,含铁聚丙烯酸酯粒度分布范围为0.2~100μm;(3) 100g of the suspension liquid of ferric tetroxide was heated to 80°C during the stirring process, added to 100g of BPO suspension liquid, continued to stir and react for 12h, the stirring speed was 600rpm, washed with water, dried and filtered to obtain the iron-containing liquid. Polyacrylate powder, the particle size distribution range of iron-containing polyacrylate is 0.2~100μm;
(4)按照粉体的质量百分含量称取89g的含铁聚丙烯酸酯,10g硫酸钡,1g的过氧化苯甲酰,均匀混合得到骨水泥粉体;(4) take by weighing the iron-containing polyacrylate of 89g, the barium sulfate of 10g, the benzoyl peroxide of 1g according to the mass percentage content of the powder, and uniformly mix to obtain the bone cement powder;
(5)按照粉液质量比2:1,取粉体100g,液体50g,将粉体加入液体中混合均匀,固化得到含铁聚丙烯酸酯骨水泥,骨水泥注射时间为10min。(5) According to the mass ratio of powder to liquid of 2:1, take 100 g of powder and 50 g of liquid, add the powder to the liquid and mix evenly, solidify to obtain iron-containing polyacrylate bone cement, and the injection time of bone cement is 10 minutes.
将含铁聚丙烯酸酯骨水泥注射到制样模具中,固化后得到直径为6.0mm长度为12mm的试样。在万能力学测试机上进行抗压强度测试,如附图1-A所示,制得的试样抗压强度为79.45MPa。The iron-containing polyacrylate bone cement was injected into the sample preparation mold, and after curing, a sample with a diameter of 6.0 mm and a length of 12 mm was obtained. The compressive strength test was carried out on a universal mechanical testing machine. As shown in Figure 1-A, the compressive strength of the prepared sample was 79.45 MPa.
实施例2Example 2
粉体含有65g的含铁聚丙烯酸酯,30g硫酸钡,5g的过氧化苯甲酰;液体含有0.5g的N,N二甲基对甲苯胺,0.05g的对苯二酚,99.45g的甲基丙烯酸甲酯。The powder contains 65g of iron-containing polyacrylate, 30g of barium sulfate, and 5g of benzoyl peroxide; the liquid contains 0.5g of N,N-dimethyl-p-toluidine, 0.05g of hydroquinone, and 99.45g of methylbenzene. Methyl acrylate.
含铁聚丙烯酸酯骨水泥及制备方法如下:The iron-containing polyacrylate bone cement and its preparation method are as follows:
(1)按照四氧化三铁:十六烷基三甲基溴化铵:甲基丙烯酸甲脂摩尔比为0.5:0.2:1将四氧化三铁115.77g、十六烷基三甲基溴化铵72.89g加入到甲基丙烯酸甲酯中100.1g,5KHz超声分散10min,再机械搅拌30min得到四氧化三铁的悬浊液体,搅拌速率为1000rpm;(1) 115.77g of ferric oxide, hexadecyl trimethyl bromide, 115.77 g of ferric tetroxide, hexadecyl trimethyl bromide according to the molar ratio of ferric oxide: cetyl trimethyl ammonium bromide: methyl methacrylate 0.5: 0.2: 1 72.89g of ammonium was added to 100.1g of methyl methacrylate, ultrasonically dispersed at 5KHz for 10min, and then mechanically stirred for 30min to obtain a suspension liquid of ferric oxide, and the stirring speed was 1000rpm;
(2)将0.2g BPO加入99.8g去离子水中,得到含有0.2%的BPO悬浊液,溶液温度为135℃,并加入0.001g十二烷基硫醇,持续搅拌6h,搅拌速率为1000rpm,;(2) 0.2g of BPO was added to 99.8g of deionized water to obtain a BPO suspension containing 0.2%, the solution temperature was 135°C, 0.001g of dodecyl mercaptan was added, and the stirring was continued for 6h at a stirring speed of 1000rpm. ;
(3)将四氧化三铁的悬浊液体100g在搅拌过程中升温到60℃,加入到100g BPO悬浊液中,持续搅拌反应36h,搅拌速率为1000rpm,水洗干燥过滤,即可得到含铁聚丙烯酸酯粉末,含铁聚丙烯酸酯粒度分布范围为0.2~100μm;(3) 100g of the suspension liquid of ferric tetroxide was heated to 60°C during stirring, added to 100g of BPO suspension, continuously stirred and reacted for 36h, the stirring speed was 1000rpm, washed with water, dried and filtered to obtain iron-containing liquid. Polyacrylate powder, the particle size distribution range of iron-containing polyacrylate is 0.2 to 100 μm;
(4)按照粉体的质量百分含量称取65g的含铁聚丙烯酸酯,30g硫酸钡,5g的过氧化苯甲酰,均匀混合得到骨水泥粉体;(4) take by weighing the iron-containing polyacrylate of 65g, the barium sulfate of 30g, the benzoyl peroxide of 5g according to the mass percentage content of the powder, and uniformly mix to obtain the bone cement powder;
(5)按照粉液质量比3:1,将60g粉体加入20g液体中混合均匀,固化得到含铁聚丙烯酸酯骨水泥,骨水泥注射时间为5min。(5) According to the mass ratio of powder to liquid of 3:1, add 60 g of powder to 20 g of liquid and mix evenly, solidify to obtain iron-containing polyacrylate bone cement, and the injection time of bone cement is 5 minutes.
将含铁聚丙烯酸酯骨水泥注射到制样模具中,固化后得到直径为6.0mm长度为12mm的试样。在万能力学测试机上进行抗压强度测试,如附图1-B所示,制得的试样抗压强度为80.82MPa。The iron-containing polyacrylate bone cement was injected into the sample preparation mold, and after curing, a sample with a diameter of 6.0 mm and a length of 12 mm was obtained. The compressive strength test was carried out on a universal mechanical testing machine. As shown in Figure 1-B, the compressive strength of the prepared sample was 80.82 MPa.
实施例3Example 3
粉体含有70g的含铁聚丙烯酸酯,27g硫酸钡,3g的过氧化苯甲酰;液体含有2g的N,N二甲基对甲苯胺,1g的对苯二酚,97g的甲基丙烯酸甲酯。The powder contains 70g of iron-containing polyacrylate, 27g of barium sulfate, and 3g of benzoyl peroxide; the liquid contains 2g of N,N-dimethyl-p-toluidine, 1g of hydroquinone, and 97g of methyl methacrylate. ester.
含铁聚丙烯酸酯骨水泥及制备方法如下:The iron-containing polyacrylate bone cement and its preparation method are as follows:
(1)按照四氧化三铁:十六烷基三甲基溴化铵:甲基丙烯酸甲脂摩尔比为0.3:0.2:1将四氧化三铁69.462g、十六烷基三甲基溴化铵72.89g加入到甲基丙烯酸甲酯中100.1g,5KHz超声分散20min,再机械搅拌20min得到四氧化三铁的悬浊液体,搅拌速率为1200rpm;(1) According to the ferric oxide: cetyl trimethyl ammonium bromide: methyl methacrylate molar ratio of 0.3: 0.2: 1, ferric oxide 69.462g, cetyl trimethyl bromide 72.89g of ammonium was added to 100.1g of methyl methacrylate, 5KHz ultrasonic dispersion was performed for 20min, and then mechanical stirring was performed for 20min to obtain a suspension liquid of ferric oxide, and the stirring speed was 1200rpm;
(2)将2g BPO加入98g去离子水中,得到含有2%的BPO悬浊液,溶液温度为110℃,持续搅拌4h,并加入0.0016g十二烷基硫醇,搅拌速率为1200rpm;(2) 2g of BPO was added to 98g of deionized water to obtain a BPO suspension containing 2%, the solution temperature was 110°C, and the solution was continuously stirred for 4h, and 0.0016g of dodecyl mercaptan was added, and the stirring rate was 1200rpm;
(3)将四氧化三铁的悬浊液体100g在搅拌过程中升温到70℃,加入到100gBPO悬浊液中,持续搅拌反应24h,搅拌速率为1200rpm,水洗干燥过滤,即可得到含铁聚丙烯酸酯粉末;(3) 100g of the suspension liquid of ferric oxide was heated to 70°C during stirring, added to 100g of BPO suspension, continuously stirred for 24h, the stirring rate was 1200rpm, washed with water, dried and filtered to obtain the iron-containing polymer Acrylic powder;
(4)按照粉体的质量百分含量称取70g的含铁聚丙烯酸酯,27g硫酸钡,3g的过氧化苯甲酰,均匀混合得到骨水泥粉体;(4) take by weighing the iron-containing polyacrylate of 70g, the barium sulfate of 27g, the benzoyl peroxide of 3g according to the mass percentage content of the powder, and uniformly mix to obtain the bone cement powder;
(5)按照粉液质量比1:1,将粉体50g加入液体50g中混合均匀,固化得到含铁聚丙烯酸酯骨水泥,骨水泥注射时间为12min。(5) According to the mass ratio of powder to liquid of 1:1, add 50 g of powder to 50 g of liquid and mix evenly, solidify to obtain iron-containing polyacrylate bone cement, and the injection time of bone cement is 12 minutes.
将骨水泥注射到制样模具中,固化后得到直径为6.0mm长度为12mm的试样。在万能力学测试机上进行抗压强度测试,如附图1-C所示,制得的试样抗压强度为75.11MPa。The bone cement was injected into the sample preparation mold, and after curing, a sample with a diameter of 6.0 mm and a length of 12 mm was obtained. The compressive strength test was carried out on a universal mechanical testing machine. As shown in Figure 1-C, the compressive strength of the prepared sample was 75.11 MPa.
本发明公开和提出的一种含铁聚丙烯酸酯骨水泥及制备方法,本领域技术人员可通过借鉴本文内容,适当改变条件路线等环节实现,尽管本发明的方法和制备技术已通过较佳实施例子进行了描述,相关技术人员明显能在不脱离本发明内容、精神和范围内对本文所述的方法和技术路线进行改动或重新组合,来实现最终的制备技术。特别需要指出的是,所有相类似的替换和改动对本领域技术人员来说是显而易见的,他们都被视为包括在本发明精神、范围和内容中。The iron-containing polyacrylate bone cement disclosed and proposed in the present invention and its preparation method can be realized by those skilled in the art by referring to the content of this article and appropriately changing the conditions and routes, although the method and preparation technology of the present invention have been implemented through better implementation. The examples are described, and those skilled in the art can obviously modify or recombine the methods and technical routes described herein without departing from the content, spirit and scope of the present invention to realize the final preparation technology. It should be particularly pointed out that all similar substitutions and modifications apparent to those skilled in the art are deemed to be included in the spirit, scope and content of the present invention.
Claims (7)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910454290.XA CN110101905A (en) | 2019-05-29 | 2019-05-29 | A kind of iron content polyacrylate bone cement and preparation method |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910454290.XA CN110101905A (en) | 2019-05-29 | 2019-05-29 | A kind of iron content polyacrylate bone cement and preparation method |
Publications (1)
Publication Number | Publication Date |
---|---|
CN110101905A true CN110101905A (en) | 2019-08-09 |
Family
ID=67492797
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201910454290.XA Pending CN110101905A (en) | 2019-05-29 | 2019-05-29 | A kind of iron content polyacrylate bone cement and preparation method |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN110101905A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2022028035A1 (en) * | 2020-08-03 | 2022-02-10 | 首都医科大学附属北京朝阳医院 | Anti-myeloma nano-bone cement, preparation method therefor and use thereof |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2008127290A2 (en) * | 2006-10-12 | 2008-10-23 | The Johns Hopkins University | Alginate and alginate lyase compositions and methods of use |
CN102070864A (en) * | 2010-12-18 | 2011-05-25 | 四川大学 | Nanoscale polymethylmethacrylate magnetic composite microsphere and preparation method thereof |
CN104826170A (en) * | 2015-04-22 | 2015-08-12 | 山东明德生物医学工程有限公司 | Development bone cement and its preparation method and use |
CN104906632A (en) * | 2015-06-19 | 2015-09-16 | 上海凯利泰医疗科技股份有限公司 | Bone cement, and preparation method and application thereof |
CN108721700A (en) * | 2018-06-27 | 2018-11-02 | 西南交通大学 | It is a kind of to have electric conductivity and magnetic bone cement and preparation method thereof concurrently |
CN109191475A (en) * | 2018-09-07 | 2019-01-11 | 博志科技有限公司 | Vertebral endplate segmentation method and device and computer readable storage medium |
-
2019
- 2019-05-29 CN CN201910454290.XA patent/CN110101905A/en active Pending
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2008127290A2 (en) * | 2006-10-12 | 2008-10-23 | The Johns Hopkins University | Alginate and alginate lyase compositions and methods of use |
CN102070864A (en) * | 2010-12-18 | 2011-05-25 | 四川大学 | Nanoscale polymethylmethacrylate magnetic composite microsphere and preparation method thereof |
CN104826170A (en) * | 2015-04-22 | 2015-08-12 | 山东明德生物医学工程有限公司 | Development bone cement and its preparation method and use |
CN104906632A (en) * | 2015-06-19 | 2015-09-16 | 上海凯利泰医疗科技股份有限公司 | Bone cement, and preparation method and application thereof |
CN108721700A (en) * | 2018-06-27 | 2018-11-02 | 西南交通大学 | It is a kind of to have electric conductivity and magnetic bone cement and preparation method thereof concurrently |
CN109191475A (en) * | 2018-09-07 | 2019-01-11 | 博志科技有限公司 | Vertebral endplate segmentation method and device and computer readable storage medium |
Non-Patent Citations (2)
Title |
---|
YI LING等: "Highly efficient magnetic hyperthermia ablation of tumors using injectable polymethylmethacrylate-Fe3O4", 《RSC ADV.》 * |
ZHIXIA LI等: "In vitro assessment of poly(methylmethacrylate)-based bone cement containing magnetite nanoparticles for hyperthermia treatment of bone tumor", 《J BIOMED MATER RES PART A》 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2022028035A1 (en) * | 2020-08-03 | 2022-02-10 | 首都医科大学附属北京朝阳医院 | Anti-myeloma nano-bone cement, preparation method therefor and use thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104922733B (en) | Injectable expansion type bone cement and preparation method thereof | |
JP6151808B2 (en) | Polymethylmethacrylate bone cement | |
CN116139332B (en) | A low-exothermic antibacterial and anti-inflammatory injectable bone cement and its preparation method | |
Engstrand et al. | Polyhedral oligomeric silsesquioxane (POSS)–poly (ethylene glycol)(PEG) hybrids as injectable biomaterials | |
CN102671245A (en) | Magnetic bone cement material and method for preparing magnetic bone cement | |
CN113880474A (en) | High-strength injectable magnesium phosphate bone cement and preparation method thereof | |
CN103007354B (en) | Enhanced calcium phosphate bone repair material and preparation method thereof | |
CN114470320A (en) | A kind of bone cement, its preparation method and application | |
Hernández et al. | Injectable acrylic bone cements for vertebroplasty based on a radiopaque hydroxyapatite. Formulation and rheological behaviour | |
JPWO2014142132A1 (en) | Adhesive bone filler and adhesive bone filler kit | |
CN110101905A (en) | A kind of iron content polyacrylate bone cement and preparation method | |
CN104784753B (en) | It is a kind of that there is the composite bone cement for reducing thermal necrosis effect | |
CN103690992A (en) | Injectable bioactive bone cement as well as preparation method and application thereof | |
Yang et al. | Effect of MMA‐g‐UHMWPE grafted fiber on mechanical properties of acrylic bone cement | |
CN116407689B (en) | Absorbable bioactive bone cement and preparation method and application thereof | |
CN113633816B (en) | Preparation method of injectable self-expanding bone cement | |
CN108815561A (en) | A kind of preparation method for the acrylic resin bone cement enhancing mechanical property and developability | |
CN115645611B (en) | High-strength self-expanding composite bone cement with osteogenic activity and preparation method thereof | |
CN104623726A (en) | Injectable water-absorbing and swelling bone cement and preparation method thereof | |
CN108096629A (en) | A kind of polymethyl methacrylate bone cement and preparation method thereof | |
CN109053968B (en) | Injectable water-absorbing expansion bone cement with high expansion ratio and preparation method thereof | |
CN106693063A (en) | Anti-collapse calcium-silicon-based composite bone cement as well as preparation method and application thereof | |
TW201544482A (en) | Modified bone cement composition | |
CN115636960A (en) | A kind of light-crosslinked silk fibroin hemostatic adhesive and preparation method thereof | |
WO2023065474A1 (en) | Calcium phosphate-based organic-inorganic composite bioactive material and preparation method therefor |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20190809 |